Vitamin B12 deficiency laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Vitamin B12 deficiency}}
{{Vitamin B12 deficiency}}
{{CMG}}
{{CMG}}
==Overview==
 
==Laboratory Findings==
==Laboratory Findings==
Deficiency is defined as serum B{{ssub|12}}levels less than 200 pg/mL (95-100% specific).  Borderline B{{ssub|12}} levels are defined between 200 and 400 pg/mL.
Deficiency is defined as serum B{{ssub|12}}levels less than 200 pg/mL (95-100% specific).  Borderline B{{ssub|12}} levels are defined between 200 and 400 pg/mL.
Line 19: Line 19:
* Methylmalonic acid: elevated in B12 deficiency (98% sensitive)  
* Methylmalonic acid: elevated in B12 deficiency (98% sensitive)  
* Homocysteine: elevated in B12 and folate deficiency  
* Homocysteine: elevated in B12 and folate deficiency  
* Anti-IF Antibodies (AB): highly specific for PA, but sensitivity only 50-84%  
* Anti-IF Antibodies (AB): highly specific for PA, but sensitivity only 50-84%  
* Anti-parietal cell ABs: less sensitive and much less specific
* Anti-parietal cell ABs: less sensitive and much less specific


==References==
==References==
{{reflist|2}}
{{Reflist|2}}
{{WH}}
 
{{WS}}
[[Category:Needs overview]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Autoimmune diseases]]
[[Category:Autoimmune diseases]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Primary care]]
{{WH}}
{{WS}}

Revision as of 19:35, 17 April 2013

Vitamin B12 deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vitamin B12 deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Schilling Test

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vitamin B12 deficiency laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vitamin B12 deficiency laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vitamin B12 deficiency laboratory findings

CDC on Vitamin B12 deficiency laboratory findings

Vitamin B12 deficiency laboratory findings in the news

Blogs on Vitamin B12 deficiency laboratory findings

Directions to Hospitals Treating Vitamin B12 deficiency

Risk calculators and risk factors for Vitamin B12 deficiency laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory Findings

Deficiency is defined as serum BTemplate:Ssublevels less than 200 pg/mL (95-100% specific). Borderline BTemplate:Ssub levels are defined between 200 and 400 pg/mL.

Serum BTemplate:Ssub levels are often low in BTemplate:Ssub deficiency, but if other features of BTemplate:Ssub deficiency are present with normal BTemplate:Ssub then the diagnosis must not be discounted. One possible explanation for normal BTemplate:Ssub levels in BTemplate:Ssub deficiency is antibody interference in people with high titres of intrinsic factor antibody.[1] Some researchers propose that the current standard norms of vitamin B12 levels are too low. In Japan, the lowest acceptable level for vitamin B12 in blood has been raised from about 200 picograms/litre (pg/l) = 145 picomol/litre (pm/l) to 550 pg/l = 400 pm/l. [2]

Serum Homocysteine and Methylmalonic acid levels are considered more reliable indicators of B12 deficiency than the concentration of B12 in blood, see for example research at the St. Louis University.[3] The levels of these substances are high in BTemplate:Ssub deficiency and can be helpful if the diagnosis is unclear. Approximately 10% of patients with vitamin B12 levels between 200-400pg/l will have a vitamin B12 deficiency on the basis of elevated levels of homocysteine and methylmalonic acid.

Routine monitoring of methylmalonic acid levels in urine is an option for people who may not be getting enough dietary BTemplate:Ssub, as a rise in methylmalonic acid levels may be an early indication of deficiency.[4]

If nervous system damage is suspected, B12 analysis in cerebrospinal fluid can also be helpful, though such an invasive test would be applicable only after unrevealing blood testing.[5]


  • Methylmalonic acid: elevated in B12 deficiency (98% sensitive)
  • Homocysteine: elevated in B12 and folate deficiency
  • Anti-IF Antibodies (AB): highly specific for PA, but sensitivity only 50-84%
  • Anti-parietal cell ABs: less sensitive and much less specific

References

  1. Hamilton MS, Blackmore S, Lee A. (2006). "Possible cause of flase normal B-12 assays (letter)". Brit Med J. 333 (7569): 654&ndash, 5.
  2. Mitsuyama Y, Kogoh H. (1988). "Serum and cerebrospinal fluid vitamin B12 levels in demented patients with CH3- B12 treatment". Japanese Journal of Psychiatry and Neurology. 42 (1): 65–71. line feed character in |title= at position 80 (help)
  3. "Test used to diagnose B12 deficiency may be inadequate". Retrieved 2007-12-04.
  4. Donaldson MS. Metabolic vitamin BTemplate:Ssub status on a mostly raw vegan diet with follow-up using tablets, nutritional yeast, or probiotic supplements. Ann Nutr Metab. 2000;44(5-6):229-34. PMID 11146329.
  5. Devalia V (2006). "Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay". Brit J Med. 333 (7564): 385–6. PMID 16916826.

Template:WH Template:WS